Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis. Ribeiro R, Yu F, Wen J, Vana A, Zhang Y Neuroscience. 2013 Sep 11. PMID: 24036373. Abstract CommentRecommendBookmarkWatch